Barnes PJ. Cytokine modulators as novel therapies for asthma. Annu Rev Pharmacol Toxicol 2002;42:81-98. [Ref.ID 64270]

Bradbury J. Tumour-tracking neural stem cells offer hope for glioma treatment. Lancet 2002;360:1226. [Ref.ID 63732]

Kay AB. Allergy and allergic diseases. First of two parts. N Engl J Med 2001;344:30-7. [Ref.ID 57126]

Bryan SA, O'Connor BJ, Matti S, Leckie MJ, Kanabar V, Khan J, Warrington SJ, Renzetti L, Rames A, Brock JA, Boyce MJ, Hansel TT, Holgate ST, Barnes PJ. Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000;356:2149-53. [Ref.ID 56256]

Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 2000;343:1467-76. [Ref.ID 53965]

Farrell GC. Clinical potential of emerging new agents in hepatitis B. Drugs 2000;60:701-10. [Ref.ID 53283]

León Prieto F, Argüelles Grande C, Botello Gil A. Perspectivas inmunoterapéuticas de la tuberculosis: citocinas y "vacunas" de ADN. Rev Clin Esp 2000;200:318-22. [Ref.ID 51777]

Delves PJ, Roitt I M. The immune systems - Second of two parts. N Engl J Med 2000;343:108-17. [Ref.ID 51763]

Gasparini G. The rationale and future potential of angiogenesis inhibitors in neoplasia. Drugs 1999;58:17-38. [Ref.ID 45222]